Aktar Mert bought KYTX
May 27, 2026 · Form 4 insider transaction
Aktar Mert bought 5,093 shares of Kyverna Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,093
Price
$0.00
Total value
N/A
InsiderAktar Mert
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 27, 2026
Filing dateMay 29, 2026
Shares owned after21,727
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 27, 2027, and (ii) immediately prior to the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.